CAR-T 细胞治疗后的感染并发症:机制、风险分层与预防 Infectious complications after CAR T-cell therapy: mechanisms, risk stratification, and prevention. PubMed 2026/06/11 发表Blood ResQ2 · IF 3.7(JCR 2025) 靶点:BCMA技术:CAR-TB 细胞恶性肿瘤地区:美国地区:韩国